Literature DB >> 16479043

Impaired systemic endothelial function in patients with pseudoexfoliation syndrome.

Pinar Tuna Atalar1, Enver Atalar, Harun Kilic, Ozlem Evren Abbasoglu, Necla Ozer, Serdar Aksöyek, Kenan Ovünç, Ferhan Ozmen, Emin Gürsel.   

Abstract

Pseudoexfoliation syndrome (PEX) is the most common clinical precursor of open-angle glaucoma. Recent studies have shown that pseudoexfoliative material is widely distributed throughout the body, including blood vessels. The aim of our study was to evaluate endothelial function in the brachial artery of patients with pseudoexfoliation syndrome. We prospectively examined 23 patients with PEX (mean age, 70 +/- 8 years) and 20 healthy age- and sex-matched individuals (mean age, 68 +/- 9 years) as a control group. Brachial artery endothelial function was assessed by vascular response to reactive hyperemia (flow-mediated dilation (FMD) and sublingual nitroglycerin (NTG-mediated dilation) using high-resolution ultrasound. Flow-mediated and NTG-induced dilation were expressed as the percent change in diameter after reactive hyperemia and after NTG administration relative to the baseline value, respectively. Patients with cardiovascular disease and other conditions associated with endothelial dysfunction were excluded. When compared with controls, patients with PEX had significantly lower flow-mediated dilation (4.5 +/- 2.8 versus 8.2 +/- 3.7, P = 0.01) and NTG-mediated dilation (10.9 +/- 3.1 versus 15.8 +/- 3.8, P = 0.0001). Flow-mediated dilation and NTG-mediated dilation were similar in PEX patients with glaucoma (n = 11) and without glaucoma (n = 12). Flow-mediated and NTG-mediated dilation did not correlate with any measured parameter in any patient or control subject. The findings indicate that systemic endothelial function is impaired in PEX syndrome patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16479043     DOI: 10.1536/ihj.47.77

Source DB:  PubMed          Journal:  Int Heart J        ISSN: 1349-2365            Impact factor:   1.862


  18 in total

1.  Serum and aqueous xanthine oxidase levels, and mRNA expression in anterior lens epithelial cells in pseudoexfoliation.

Authors:  Huseyin Simavli; Mehmet Tosun; Yasin Y Bucak; Mesut Erdurmus; Zeynep Ocak; Halil I Onder; Muradiye Acar
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-05-10       Impact factor: 3.117

2.  Plasma adropin level in patients with pseudoexfoliation.

Authors:  Tevfik Oğurel; Reyhan Oğurel; Mustafa Topuz; Nurgül Örnek; Kemal Örnek
Journal:  Int Ophthalmol       Date:  2016-02-10       Impact factor: 2.031

3.  Association of ocular pseudoexfoliation syndrome with ischaemic heart disease, arterial hypertension and diabetes mellitus.

Authors:  Martynas Spečkauskas; Abdonas Tamošiūnas; Vytautas Jašinskas
Journal:  Acta Ophthalmol       Date:  2012-05-02       Impact factor: 3.761

4.  Atherogenic indices in pseudoexfoliation syndrome.

Authors:  Enver Mirza
Journal:  Eye (Lond)       Date:  2019-07-05       Impact factor: 3.775

5.  High-sensitivity C-reactive Protein and Tumor Necrosis Factor Alpha in Pseudoexfoliation Syndrome.

Authors:  Rana Sorkhabi; Amir Ghorbanihaghjo; Mohamadhossein Ahoor; Mehriar Nahaei; Nadereh Rashtchizadeh
Journal:  Oman Med J       Date:  2013-01

6.  Link of ocular pseudoexfoliation syndrome and vascular system changes: results from 10-year follow-up study.

Authors:  Ugnė Rumelaitienė; Dalia Žaliūnienė; Martynas Špečkauskas; Abdonas Tamošiūnas; Ričardas Radišauskas; Emilija Jusevičiūtė; Vidas Vainauskas; Gailutė Bernotienė
Journal:  Int Ophthalmol       Date:  2020-01-19       Impact factor: 2.031

Review 7.  Pseudoexfoliation syndrome and cardiovascular diseases.

Authors:  Georgios K Andrikopoulos; Dimitrios K Alexopoulos; Sotirios P Gartaganis
Journal:  World J Cardiol       Date:  2014-08-26

Review 8.  Ocular Pseudoexfoliation Syndrome Linkage to Cardiovascular Disease.

Authors:  Juan A Siordia; Jimena Franco; Todd R Golden; Bilal Dar
Journal:  Curr Cardiol Rep       Date:  2016-07       Impact factor: 2.931

9.  Endothelial cell markers in patients with pseudoexfoliation syndrome.

Authors:  Joanna Stafiej; Grażyna Malukiewicz; Hanna Lesiewska-Junk; Danuta Rość; Karolina Kaźmierczak
Journal:  ScientificWorldJournal       Date:  2012-04-19

10.  Is pseudoexfoliation syndrome associated with coronary artery disease?

Authors:  Mehmet Yunus Emiroglu; Erol Coskun; Hekim Karapinar; Musa Capkın; Zekeriya Kaya; Hasan Kaya; Mustafa Akcakoyun; Ramazan Kargin; Zeki Simsek; Göksel Acar; Soe Moe Aung; Selcuk Pala; Burak Ozdemir; Ali Metin Esen; Cevat Kırma
Journal:  N Am J Med Sci       Date:  2010-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.